• Product NameTRAF7 antibody
• Host SpeciesRabbit
• ClonalityPolyclonal
• PurificationAntibodies were purified by affinity purification using immunogen.
• ApplicationsWB
• Species ReactivityHuman
• SpecificityThe antibody detects endogenous level of total TRAF7 protein.
• Immunogen TypePeptide
• Immunogen DescriptionA synthetic peptide of human TRAF7.
• Target NameTRAF7
• Alternative Names    RFWD1; RNF119;
• Accession No. Swiss-Prot#: Q6Q0C0
  NCBI Gene ID: 84231
• UniprotQ6Q0C0
• Gene ID84231;
• SDS-PAGE MW 67kd
• Concentration 1.0mg/ml
• Formulation Supplied at 1.0mg/mL in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
• Storage Store at -20˚C

• WB 1:500 - 1:2000

Tumor necrosis factor (TNF; see MIM 191160) receptor-associated factors, such as TRAF7, are signal transducers for members of the TNF receptor superfamily (see MIM 191190). TRAFs are composed of an N-terminal cysteine/histidine-rich region containing zinc RING and/or zinc finger motifs; a coiled-coil (leucine zipper) motif; and a homologous region that defines the TRAF family, the TRAF domain, which is involved in self-association and receptor binding.

• Western blot analysis of extracts of various cell lines, using TRAF7 at 1:1000 dilution.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting